Oh Young Bang/LinkedIn
Nov 9, 2025, 12:28
Oh Young Bang on Enhancement of Post-Stroke Neuroregeneration
Oh Young Bang, Professor of Neurology at Samsung Medical Center, CEO at S and E bio, shared on LinkedIn:
”We’re confirming safety in stroke patients first, then moving on to drug-loaded exosome treatments for neurodegeneration (PMID: 40883738).
The BBB-bypass approach would be key.”
Read the full article here.
Article: Engineered MSC-EVs loaded with BDNF-enhancing neuropeptides via a non-disruptive method enhance post-stroke neuroregeneration via intranasal delivery
Authors: Ji-Eun Kim, Ye Eun Ji, Hyeon Jun Hwang, Ga-Eun Go, Hyung-Jun Lim, Jaein Yoo, Jooho Kim, Doil Park, Eun Hee Kim, Doory Kim, Oh Young Bang
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 9, 2025, 12:37Deise Catamo Vaz Wins Merit Award for Raising Stroke Awareness in Mozambique
-
Nov 9, 2025, 12:34Abena Ntim Asamoah on The Race to End Preventable Maternal Deaths in Africa
-
Nov 9, 2025, 12:34Christian Schulze Shares the CLOSURE AF Insights on Left Atrial Appendage in AFib
-
Nov 9, 2025, 12:33C Michael Gibson and Ulf Landmesser Discuss Insights from CLOSURE-AF trial
-
Nov 9, 2025, 12:32Shakira J Grant on How can AI Transform Outcomes for Patients Who Need It Most?
-
Nov 9, 2025, 12:32Amre Nouh and Ahmed Koriesh on The Future of Post-Stroke Care
-
Nov 9, 2025, 12:31Teagan Prouse and Colleagues on Alternate Functions of Physiological Anticoagulants
-
Nov 9, 2025, 12:30Hema Tallman Congratulates Richard Wilner on Receiving the Sustainability in Life Sciences Award
-
Nov 9, 2025, 12:29Sophie Hordijk on A New Cause of the Hereditary Bleeding Disorder of VWD Type 1